| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 721 | 2021 |
| Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01 J Weiner, P Suwalski, M Holtgrewe, A Rakitko, C Thibeault, M Mueller, ... EClinicalMedicine 40, 2021 | 71 | 2021 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... Human molecular genetics 31 (23), 3945-3966, 2022 | 68* | 2022 |
| Metformin Attenuates ROS via FOXO3 Activation in Immune Cells J Hartwig, M Loebel, S Steiner, S Bauer, Z Karadeniz, C Roeger, C Skurk, ... Frontiers in immunology 12, 581799, 2021 | 30 | 2021 |
| Knockdown of Indy/CeNac2 extends Caenorhabditis elegans life span by inducing AMPK/aak-2 F Schwarz, Z Karadeniz, A Fischer-Rosinsky, DM Willmes, J Spranger, ... Aging (Albany NY) 7 (8), 553, 2015 | 29 | 2015 |
| Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up‐regulating matrix metalloproteinase 9 expression in mice A Jenke, R Schur, C Röger, Z Karadeniz, M Grüger, L Holzhauser, ... Physiological reports 5 (24), e13523, 2017 | 20 | 2017 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 14 | 2023 |
| Lung image: inflammatory myofibroblastic tumor S Karapolat, KN Seyis, S Ersoz, A Buran, ZM Karadeniz Lung 195, 387-388, 2017 | 10 | 2017 |
| Highly multiplexed immune repertoire sequencing links multiple lymphocyte classes with severity of response to COVID-19 R Dannebaum, P Suwalski, H Asgharian, G Du Zhipei, H Lin, J Weiner, ... EClinicalMedicine 48, 2022 | 6 | 2022 |
| HLA-C* 04:01 is a Genetic Risk Allele for Severe Course of COVID-19 W January 3rd, S Phillip, H Manuel, T Charlotte, M Müller, P Dimitri, ... MedRxiv, 2020.12. 21.20248121, 2020 | 4 | 2020 |
| Sağlık sektöründe performans değerlendirmesi: İstanbul il sağlık müdürlüğünde yapılan araştırma Z Karadeniz Sosyal Bilimler Enstitüsü, 2019 | 2 | 2019 |
| Male carriers of HLA-C* 04: 01 have increased risk of cardiac injury in COVID-19 P Suwalski, M Violano, M Müller, D Patriki, C Thibeault, C Quedenau, ... Journal of Cardiovascular Aging 2 (3), 33, 2022 | 1 | 2022 |
| First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study D Soll, P Bischoff, A Frisch, M Jensen, Z Karadeniz, MT Mogl, D Horst, ... BMC Endocrine Disorders 24 (1), 25, 2024 | | 2024 |
| Foxo3a and cardiac myofibroblast transdifferentiation after myocardial infarction Z Karadeniz, P Schenkenberger, H Maatz, E Lindberg, T Haase, A Thiele, ... European Heart Journal 44 (Supplement_2), ehad655. 3121, 2023 | | 2023 |
| FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy K Makrutzki-Zlotek, F Escher, Z Karadeniz, G Aleshcheva, H Pietsch, ... Heart 109 (11), 846-856, 2023 | | 2023 |
| Effects of Foxo3a on Immune Response and Remodeling After Myocardial Infarction Z Karadeniz Technische Universität Berlin, 2023 | | 2023 |
| New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations (preprint) F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... | | 2021 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations (preprint) F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... | | 2021 |
| Novel effects of Foxo3a on immune system and cardiac remodeling after myocardial infarction Z Karadeniz, J Winter, E Smeir, J Hartwig, E Na, N Kraenkel, J Kurreck, ... European Heart Journal 41 (Supplement_2), ehaa946. 3643, 2020 | | 2020 |
| HLA-C* 04: 01 is a Genetic Risk Allele for Severe Course of COVID-19 (preprint) J Weiner III, P Suwalski, M Holtgrewe, C Thibeault, M Mueller, D Patriki, ... | | 2020 |
